|
|||||
|
|
The value of tumor markers in men with metastatic prostate cancer undergoing [177Lu]Lu-PSMA therapy |
|
| Authors: | Anna Yordanova MD Paula Linden Stefan Hauser MD Georg Feldmann MD Peter Brossart MD Rolf Fimmers PhD Markus Essler MD Stefan Holdenrieder MD Hojjat Ahmadzadehfar MD |
| Affiliation: | 1. Department of Nuclear Medicine, University Hospital Bonn, Bonn, Germany;2. Department of Urology, University Hospital Bonn, Bonn, Germany;3. Department of Internal Medicine 3, University Hospital Bonn, Bonn, Germany;4. Institute for Medical Biometry, Informatics and Epidemiology, University of Bonn, Bonn, Germany;5. Institute for Laboratory Medicine, German Heart Centre, Technical University of Munich, Munich, Germany |
| Abstract: | |
| Keywords: | prostate cancer PSMA radioligand therapy tumor markers |